Anthem Blue Cross (HMO, PPO, EPO)
Treanda 180 Mg/2 Ml Soln (bendamustine)
Drugs for Cancer : Drugs for Cancer
  • Chronic Lymphocytic Leukemia:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: Payer Specific
    Diagnosis Types: 1 of Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma

    Multiple Myeloma:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: NCCN Guidelines
    ECOG Score Requirement in Policy: N/A
    ECOG status <=2: No
    Diagnosis Types: Other recommended regimens for previously treated MM bendamustine/bortezomib/dexamethasone;Other recommended regimens for previously treated MM: Bendamustine/Lenalidomide/Dexamethasone
    Policy Allows for Use as Combination Therapy: No
    Policy Allows for Use Monotherapy Therapy: No

  • Prior Authorization: Documented Diagnosis: Yes
    Duration: 1 year(s)